These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 8635096

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. High growth fraction at 9 grays of radiotherapy is associated with a good prognosis for patients with cervical squamous cell carcinoma.
    Oka K, Suzuki Y, Nakano T.
    Cancer; 2000 Oct 01; 89(7):1526-31. PubMed ID: 11013367
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prognostic implication of proliferative markers MIB-1 and PC10 in esophageal squamous cell carcinoma.
    Lam KY, Law SY, So MK, Fok M, Ma LT, Wong J.
    Cancer; 1996 Jan 01; 77(1):7-13. PubMed ID: 8630942
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Image cytometric comparison of proliferating cell nuclear antigen and MIB-1 staining in hepatocellular carcinoma and adjacent liver tissue.
    Wells SJ, DeRose PB, Cohen C.
    Cytometry; 1996 Sep 15; 26(3):198-203. PubMed ID: 8889391
    [Abstract] [Full Text] [Related]

  • 9. Clinical evaluation of serum and immunohistochemical expression of SCC and CA19-9 in radiation therapy for cervical cancer.
    Abe A, Nakano T, Morita S, Oka K.
    Anticancer Res; 1999 Sep 15; 19(1B):829-36. PubMed ID: 10216501
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Transient increases of growth fraction during fractionated radiation therapy for cervical carcinoma. Ki-67 and PC10 immunostaining.
    Oka K, Nakano T, Hoshi T.
    Cancer; 1993 Nov 01; 72(9):2621-7. PubMed ID: 8402484
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunohistochemical assessment of proliferation rate of breast carcinoma cells using Ki-67, MIB-1 and anti-PCNA monoclonal antibodies.
    Markiewski M, Domagała W.
    Pol J Pathol; 1996 Nov 01; 47(4):189-94. PubMed ID: 9097711
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.
    Lee CS.
    Cancer; 1996 Nov 01; 78(9):1881-7. PubMed ID: 8909306
    [Abstract] [Full Text] [Related]

  • 16. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A, Posch B, El-Baz M, Mokhtar AA, Susani M, Ghoneim MA, Marberger M.
    J Urol; 2001 May 01; 165(5):1481-7. PubMed ID: 11342901
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.